Skip to main content
NCBI home page
Cancer Cell International logoLink to Cancer Cell International
. 2020 Jul 17;20:318. doi: 10.1186/s12935-020-01375-9

Correction to: RETRACTED ARTICLE: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells

Yang Hu 1, Hong Xie 1, Yankun Liu 1, Weiying Liu 1, Min Liu 1, Hua Tang 1,✉
PMCID: PMC7367254  PMID: 32694940

Correction to: Cancer Cell Int (2017) 17:36 10.1186/s12935-017-0407-9

Following publication of the original article [1], the authors notified us the transwell invasion image for ASO-NC of HeLa cell in Fig. 3b was wrongly placed by mistake during the preparation of the figure. The corrected version of Fig. 3b is provided below (in the red box). This correction does not change the conclusions of this paper.graphic file with name 12935_2020_1375_Figa_HTML.jpg

Footnotes

The article to which this update relates has been retracted. Please see the retraction notice for more detail: 10.1186/s12935-021-01958-0

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Hu Y, Xie H, Liu Y, Liu W, Liu M, Tang H. miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells. Cancer Cell Int. 2017;17:36. doi: 10.1186/s12935-017-0407-9. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES